Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. | Prostate | 2017 | 28631436 | PubTator, text mining | PubMed |
| Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies. | Cancer Sci | 2017 | 28622427 | PubTator, text mining | PubMed |
| Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro. | Cancer Gene Ther | 2017 | 28621316 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | Proc Natl Acad Sci U S A | 2017 | 28611215 | PubTator, text mining | PubMed |
| Cellular immunity augmentation in mainstream oncologic therapy. | Cancer Biol Med | 2017 | 28607803 | PubTator, text mining | PubMed |
| When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study. | BMC Urol | 2017 | 28606069 | PubTator, text mining | PubMed |
| Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. | Cancer Immunol Immunother | 2017 | 28601925 | PubTator, text mining | PubMed |
| Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA. | Int J Mol Sci | 2017 | 28555048 | PubTator, text mining | PubMed |
| Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial. | Front Pharmacol | 2017 | 28539888 | PubTator, text mining | PubMed |
| Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. | Biomedicines | 2017 | 28536346 | PubTator, text mining | PubMed |
| Covalent inhibition of protein tyrosine phosphatases. | Mol Biosyst | 2017 | 28534914 | PubTator, text mining | PubMed |
| Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility. | Ther Adv Med Oncol | 2017 | 28529549 | PubTator, text mining | PubMed |
| Architecture of the human interactome defines protein communities and disease networks. | Nature | 2017 | 28514442 | PubTator, text mining | PubMed |
| Defects in the acid phosphatase ACPT cause recessive hypoplastic amelogenesis imperfecta. | Eur J Hum Genet | 2017 | 28513613 | PubTator, text mining | PubMed |
| HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins. | Viruses | 2017 | 28505117 | PubTator, text mining | PubMed |
| Cell growth inhibition and apoptotic effects of a specific anti-RTFscFv antibody on prostate cancer, but not glioblastoma, cells. | F1000Res | 2017 | 28491282 | PubTator, text mining | PubMed |
| An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors. | Clin Proteomics | 2017 | 28491011 | PubTator, text mining | PubMed |
| Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study. | Int J Mol Sci | 2017 | 28471417 | PubTator, text mining | PubMed |
| Small Cell Carcinoma of the Prostate: A Case Report and Brief Review of the Literature. | Urol Case Rep | 2017 | 28462157 | PubTator, text mining | PubMed |
| The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort. | Oncotarget | 2017 | 28460462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=56